Nectar Lifesciences Share Price

₹ 10.24

+₹0.06 (0.59%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: NECLIFE
|
Pharmaceuticals

Nectar Lifesciences Share Price Today

As of 4 Nov 2026, Nectar Lifesciences share price is ₹10.24. The stock opened at ₹10.18, compared to its previous close of ₹10.18. During today's trading session, Nectar Lifesciences share price moved in the range of ₹10.10 to ₹10.35, with an average price of ₹10.22 for the day. Looking at its last 52-week, the stock has touched a low of ₹9.30 and a high of ₹22.40.

Share price over the last 1 day rose from 10.18 to 10.24, ranging between 10.11 and 10.35.
₹10.10
0.59% up today
₹10.35
1D LOW
1D HIGH

Nectar Lifesciences Stock Insights

Latest Earning
Op Profit TrendUp by 56.75% QoQ
Latest Earning
Net Profit TrendUp by 77.33% QoQ
Latest Earning
Revenue TrendUp by 394.15% YoY
Stock Performance
OutperformingBeat Nifty by 1.45 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 4.26%
Shareholding Pattern
FIIFII decreased stake by 0.10%
Nectar Lifesciences stock performance
Open₹10.18
High₹10.35
Low₹10.10
Prev. close₹10.18
Nectar Lifesciences trading activity
Volume59,973
Average traded price₹10.22
Last traded time03:29:31 03 Nov
Last traded quantity25
Circuit
L
H
₹9.64
₹10.64
52-week
L
H
₹9.30
₹22.40
Mkt Cap Cr
197.56
P/E
-0.81
P/B
0.34
ROA
-39.42%
ROE
-9.85%
ROCE
-8.75%
Quick Ratio
9.7
EV/EBITDA
-0.35

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Nectar Lifesci. has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Nectar Lifesci. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Nectar Lifesci. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4784.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,26,811.2894.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Nectar Lifesciences Company Background

ISIN
INE023H01027
Sector Market Cap
₹ 197.56 Cr

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Nectar Lifesciences Financial Highlights

  • Revenue: Nectar Lifesciences reported revenue of ₹9.29 crore in FY26 vs ₹1.88 crore in FY25. It showed an increase of 394.15% on a yearly basis.
  • Operating Profit: Nectar Lifesciences reported an operating loss of ₹87.88 crore in FY26 vs ₹1.07 crore in FY25. It showed a decrease of 8,313.08% on a year-on-year basis.
  • Net Profit: Nectar Lifesciences reported a net loss of ₹292.89 crore in FY26 vs ₹113.68 crore in FY25. It showed a decrease of 157.64% on a yearly basis.

Nectar Lifesciences Quarterly Result Highlights

  • Nectar Lifesciences reported revenue of ₹3.36 crore in Jun 2026, compared with ₹7.58 crore in Mar 2026, representing a decrease of 55.67% on a quarter-on-quarter (QoQ) basis.
  • Nectar Lifesciences reported an operating loss of ₹24.62 crore in Jun 2026, compared with ₹56.93 crore in Mar 2026, representing an increase of 56.75% on a quarter-on-quarter (QoQ) basis.
  • Nectar Lifesciences reported a loss of ₹15.40 crore in Jun 2026, compared with ₹67.92 crore in Mar 2026, reflecting an increase of 77.33% on a QoQ basis.
  • The earnings per share (EPS) of Nectar Lifesciences stood at ₹13.40 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.84%
FII
0.50%
Other DII
3.90%
Retail and other
43.76%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jan 20260.58%
Mar 20260.60%
Jun 20260.50%
Sep 20260.50%

Nectar Lifesciences Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Nectar Lifesciences Share Price History

Nectar Lifesciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹10.18 / ₹10.14
-0.39%
02 Nov 26
₹10.40 / ₹10.18
-0.20%
30 Oct 26
₹10.43 / ₹10.20
-1.26%
29 Oct 26
₹10.36 / ₹10.33
-0.10%
Show more

Nectar Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.00₹0.00₹1,684.09₹1,523.67
Other Income₹9.29₹1.88₹14.58₹43.18
Total Revenue₹9.29₹1.88₹1,698.66₹1,566.85
Total Expenses₹97.17₹0.81₹1,680.39₹1,609.27
Profit Before Tax-₹87.88₹1.07₹18.27-₹42.42
Tax-₹30.53₹0.38₹13.27-₹18.24
Profit After Tax-₹57.35₹0.70₹5.00-₹24.18
EPS - Basic-₹13.40-₹5.07₹0.22-₹1.08
EPS - Diluted-₹13.40-₹5.07₹0.22-₹1.08

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹788.91-₹161.53₹18.27-₹42.42
Income before WC changes-₹554.67-₹22.51₹155.82₹55.73
Change in Assets₹606.85₹170.62-₹44.77₹150.36
Change in Liabilities-₹400.90₹21.33₹113.63-₹72.43
Change in WC₹205.95₹191.95₹68.87₹77.93
Cash flow from Operations-₹348.72₹169.44₹224.69₹133.65
Cash flow from Investing₹1,208.15-₹41.93-₹17.03₹51.70
Cash flow from Financing-₹766.51-₹128.09-₹205.44-₹185.58
Total Cash Flow₹92.91-₹0.58₹2.23-₹0.23
Cash (Start of the year)₹19.22₹19.81₹17.58₹17.81
Cash (End of the year)₹112.14₹19.22₹19.81₹17.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹368.64₹809.64₹907.23₹958.03
Current Assets₹252.97₹1,237.59₹1,283.83₹1,231.18
Total Assets₹621.61₹2,047.23₹2,191.06₹2,189.21
Current Liabilities₹26.05₹1,021.54₹972.82₹890.93
Net Current Asset₹226.92₹216.05₹311.02₹340.26
Non-Current Liabilities₹13.26₹69.58₹148.99₹233.69
Equity Capital₹582.30₹956.11₹1,069.25₹1,064.60
Total Equity & Liabilities₹621.61₹2,047.23₹2,191.06₹2,189.21

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.00₹0.00₹1,684.09₹1,523.67
Other Income₹9.29₹1.88₹14.58₹43.18
Total Revenue₹9.29₹1.88₹1,698.66₹1,566.85
Total Expenses₹97.16₹0.81₹1,680.39₹1,607.54
Profit Before Tax-₹87.87₹1.07₹18.28-₹40.69
Tax-₹30.53₹0.38₹13.27-₹18.24
Profit After Tax-₹57.34₹0.70₹5.00-₹22.46
EPS - Basic-₹13.40-₹5.07₹0.22-₹1.00
EPS - Diluted-₹13.40-₹5.07₹0.22-₹1.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹788.90-₹161.53₹18.28-₹40.69
Income before WC changes-₹554.67-₹22.51₹155.83₹56.39
Change in Assets₹508.21₹170.62-₹44.77₹149.33
Change in Liabilities-₹370.90₹21.33₹113.63-₹72.35
Change in WC₹137.31₹191.95₹68.87₹76.98
Cash flow from Operations-₹417.35₹169.44₹224.69₹133.37
Cash flow from Investing₹1,205.41-₹41.93-₹17.03₹52.03
Cash flow from Financing-₹699.15-₹128.09-₹205.44-₹185.57
Total Cash Flow₹88.91-₹0.58₹2.23-₹0.17
Cash (Start of the year)₹19.22₹19.80₹17.57₹17.74
Cash (End of the year)₹108.13₹19.22₹19.80₹17.57

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹362.78₹809.65₹907.23₹958.04
Current Assets₹249.57₹1,237.58₹1,283.83₹1,231.18
Total Assets₹612.34₹2,047.23₹2,191.06₹2,189.21
Current Liabilities₹25.97₹1,021.54₹972.82₹890.93
Net Current Asset₹223.60₹216.04₹311.01₹340.25
Non-Current Liabilities₹4.07₹69.58₹148.99₹233.69
Equity Capital₹582.31₹956.11₹1,069.25₹1,064.60
Total Equity & Liabilities₹612.34₹2,047.23₹2,191.06₹2,189.21
* All values are in INR Crore
Nectar Lifesciences market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Nectar Lifesciences technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
42.3
Neutral
ATR (14)
0.52
Neutral
STOCH(9,6)
20.11
Bullish
STOCH RSI (14)
29.06
Neutral
ADX(9)
20.84
Bearish
UO(9)
37.91
Neutral
ROC(12)
0.2
Bullish
WillR(14)
-79.89
Neutral
Period
Simple value
Exponential vaue
5D
10.32
10.3
10D
10.54
10.39
20D
10.46
10.51
50D
11.04
10.79
100D
11.05
11.07
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Nectar Lifesciences
Pharmaceuticals
Add Stock
Add Another

Nectar Lifesciences Returns Calculator

Nectar Lifesciences Latest News

3 months ago
Upcoming dividends, stock splits, bonuses this week: Canara Robeco AMC, Nectar Lifesciences, Nuvama Wealth among others in focus
Showing news item 1 of 1

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Nectar Lifesciences Share Price FAQs

Please be aware that Nectar Lifesciences stock prices are subject to continuous fluctuations due to various factors.